121 related articles for article (PubMed ID: 36385399)
1. Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group.
Yanagisawa R; Tamaki M; Tanoshima R; Misaki Y; Uchida N; Koi S; Tanaka T; Ozawa Y; Matsuo Y; Tanaka M; Ikegame K; Katayama Y; Matsuoka KI; Ara T; Kanda Y; Matsumoto K; Fukuda T; Atsuta Y; Kato M; Nakasone H
Hematol Oncol; 2023 Aug; 41(3):535-545. PubMed ID: 36385399
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk factors for fatal renal complications after allogeneic hematopoietic cell transplantation.
Yanagisawa R; Koyama H; Yakushijin K; Uchida N; Jinguji A; Takeda W; Nishida T; Tanaka M; Eto T; Ohigashi H; Ikegame K; Matsuoka KI; Katayama Y; Kanda Y; Sawa M; Kawakita T; Onizuka M; Fukuda T; Atsuta Y; Shinohara A; Nakasone H
Bone Marrow Transplant; 2024 Mar; 59(3):325-333. PubMed ID: 38104219
[TBL] [Abstract][Full Text] [Related]
3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
4. Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group.
Kimura SI; Kameda K; Harada K; Saburi M; Okinaka K; Shinohara A; Uchida N; Nishijima A; Ozawa Y; Tanaka M; Kuriyama T; Katayama Y; Sawa M; Ikegame K; Kawakita T; Kanda Y; Nakamae H; Ara T; Kimura T; Sato A; Fukuda T; Atsuta Y; Nakasone H
Transplant Cell Ther; 2022 Apr; 28(4):209.e1-209.e9. PubMed ID: 34995815
[TBL] [Abstract][Full Text] [Related]
5. The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT).
Ishida S; Doki N; Shingai N; Yoshioka K; Kakihana K; Sakamaki H; Ohashi K
Ann Hematol; 2016 Jun; 95(7):1145-50. PubMed ID: 27079957
[TBL] [Abstract][Full Text] [Related]
6. Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.
Nakamae H; Kirby KA; Sandmaier BM; Norasetthada L; Maloney DG; Maris MB; Davis C; Corey L; Storb R; Boeckh M
Biol Blood Marrow Transplant; 2009 Jun; 15(6):694-703. PubMed ID: 19450754
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Risk Scoring Systems in HLA-Matched Related Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Cohort Study.
Aladağ E; Demiroğlu H; Büyükaşık Y; Göker H
Turk J Haematol; 2021 Jun; 38(2):138-144. PubMed ID: 32539316
[TBL] [Abstract][Full Text] [Related]
8. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic Cell Transplantation-Comorbidity Index Score Is Correlated with Treatment-Related Mortality and Overall Survival following Second Allogeneic Hematopoietic Cell Transplantation in Children.
Forlanini F; Zinter MS; Dvorak CC; Bailey-Olson M; Winestone LE; Shimano KA; Higham CS; Melton A; Chu J; Kharbanda S
Transplant Cell Ther; 2022 Mar; 28(3):155.e1-155.e8. PubMed ID: 34848362
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Vergara-Cadavid J; Johnson PC; Kim HT; Yi A; Sise ME; Leaf DE; Hanna PE; Ho VT; Cutler CS; Antin JH; Gooptu M; Kelkar AH; Wells SL; Nikiforow S; Koreth J; Romee R; Soiffer RJ; Shapiro RM; Gupta S
Transplant Cell Ther; 2023 Jul; 29(7):455.e1-455.e9. PubMed ID: 37015320
[TBL] [Abstract][Full Text] [Related]
11. Late cardiovascular complications after hematopoietic cell transplantation.
Chow EJ; Wong K; Lee SJ; Cushing-Haugen KL; Flowers ME; Friedman DL; Leisenring WM; Martin PJ; Mueller BA; Baker KS
Biol Blood Marrow Transplant; 2014 Jun; 20(6):794-800. PubMed ID: 24565992
[TBL] [Abstract][Full Text] [Related]
12. Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.
Tomblyn MR; Ewell M; Bredeson C; Kahl BS; Goodman SA; Horowitz MM; Vose JM; Negrin RS; Laport GG
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1051-7. PubMed ID: 21073974
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus disease after hematopoietic cell transplantation: A Japanese transplant registry analysis.
Inamoto Y; Takeda W; Hirakawa T; Sakaguchi H; Nakano N; Uchida N; Doki N; Ikegame K; Katayama Y; Sawa M; Kuriyama T; Hiramoto N; Ota S; Ozawa Y; Kataoka K; Kanda Y; Hino M; Kimura T; Atsuta Y; Fukuda T; Nagafuji K
Am J Hematol; 2022 Dec; 97(12):1568-1579. PubMed ID: 36087061
[TBL] [Abstract][Full Text] [Related]
15. Reducing Treatment-Related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A University of Michigan Prospective Series.
Pawarode A; Mineishi S; Reddy P; Braun TM; Khaled YA; Choi SW; Magenau JM; Harris AC; Connelly JA; Kitko CL; Parkin BL; Goldstein SC; Yanik GA; Levine JE; Ferrara JL; Couriel DR
Biol Blood Marrow Transplant; 2016 Jan; 22(1):54-60. PubMed ID: 26211984
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus reactivation is associated with an increased risk of late-onset invasive aspergillosis independently of grade II-IV acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation: JSTCT Transplant Complications Working Group.
Kimura SI; Tamaki M; Okinaka K; Seo S; Uchida N; Igarashi A; Ozawa Y; Ikegame K; Eto T; Tanaka M; Shiratori S; Nakamae H; Sawa M; Kawakita T; Onizuka M; Fukuda T; Atsuta Y; Kanda Y; Nakasone H
Ann Hematol; 2021 Dec; 100(12):3029-3038. PubMed ID: 34490500
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].
Wang CY; Ren HY; Qiu ZX; Wang Y; Cen XN; Wang LH; Wang MJ; Xu WL; Wang WS; Li Y; Dong YJ; Ou JP; Liang ZY; Liu W; Wang Q
Zhonghua Xue Ye Xue Za Zhi; 2013 Aug; 34(8):659-63. PubMed ID: 23978015
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
[TBL] [Abstract][Full Text] [Related]
19. Risk factors and outcome of Stenotrophomonas maltophilia infection after allogeneic hematopoietic stem cell transplantation: JSTCT, Transplant Complications Working Group.
Saburi M; Oshima K; Takano K; Inoue Y; Harada K; Uchida N; Fukuda T; Doki N; Ikegame K; Matsuo Y; Katayama Y; Ozawa Y; Matsuoka KI; Kawakita T; Mori Y; Ara T; Nakamae H; Kimura T; Kanda Y; Atsuta Y; Ogata M;
Ann Hematol; 2023 Sep; 102(9):2507-2516. PubMed ID: 37338625
[TBL] [Abstract][Full Text] [Related]
20. Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program.
McDonald MK; Culos KA; Gatwood KS; Prow C; Chen H; Savani BN; Byrne M; Kassim AA; Engelhardt BG; Jagasia M; Satyanarayana G
Biol Blood Marrow Transplant; 2018 Oct; 24(10):2081-2087. PubMed ID: 29753159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
